Oculoplastic, Orbital and Lacrimal Division, Department of Ophthalmology, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel.
Dermatol Surg. 2010 Sep;36(9):1412-8. doi: 10.1111/j.1524-4725.2010.01650.x. Epub 2010 Jul 9.
Lower lid involutional entropion is a common eyelid pathology affecting the elderly population. Most of the reported surgical techniques are mainly based on a lateral tarsal strip anchored to the orbital rim.
To report the surgical outcome using a simple single-stitch lateral wedge technique to repair involutional lower entropion.
This single-surgeon, retrospective, noncomparative cases series included all patients with involutional lower eyelid entropion who were operated on using the lateral wedge technique.
Fifty-eight eyelids of 52 patients (46 unilateral, 6 bilateral; 27 men, 25 women; age, mean 67 ± 10; range 50-85) underwent surgical repair. Immediate resolution of entropion and associated ocular symptoms was achieved in 55 eyelids (94.9%). One case had postoperative ectropion that completely resolved spontaneously after 4 weeks, and one had wound dehiscence that healed completely without any intervention. Another patient had residual entropion that resolved after an additional surgical repair. No other cases of recurrence were noted during a mean follow-up period of 16 months (range 6-24 months).
This minimally invasive single-stitch lateral wedge technique is a simple and effective procedure for repairing involutional lower eyelid entropion and is associated with low recurrence and complication rates. Igal Leibovitch, MD, has indicated no significant interest with commercial supporters.
下眼睑退行性内翻是一种常见的影响老年人群的眼睑病理。大多数报道的手术技术主要基于外侧睑板条固定在眶缘。
报告使用简单的单缝外侧楔形技术修复退行性下内翻的手术结果。
本研究为单外科医生、回顾性、非对照病例系列，包括所有接受外侧楔形技术手术的退行性下眼睑内翻患者。
52 例患者（46 例单侧，6 例双侧；27 例男性，25 例女性；年龄，平均 67±10；范围 50-85）的 58 只眼接受了手术修复。55 只眼（94.9%）立即解决了内翻和相关的眼部症状。1 例术后出现外眦，4 周后自发完全缓解，1 例伤口裂开，无需任何干预即可完全愈合。另 1 例有残余内翻，经再次手术修复后得到解决。在平均 16 个月（6-24 个月）的随访期间，没有其他复发的病例。
这种微创的单缝外侧楔形技术是修复退行性下眼睑内翻的简单有效方法，其复发和并发症发生率低。Igal Leibovitch，医学博士，表示与商业支持者没有重大利益关系。
